Sylvain Arnould

2.0k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Sylvain Arnould is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sylvain Arnould has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sylvain Arnould's work include CRISPR and Genetic Engineering (8 papers), CAR-T cell therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Sylvain Arnould is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), CAR-T cell therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Sylvain Arnould collaborates with scholars based in France, United Kingdom and Spain. Sylvain Arnould's co-authors include Frédéric Pâques, Aymeric Duclert, Julianne Smith, Philippe Duchâteau, Sylvestre Grizot, Jean-Charles Epinat, Jesús Prìeto, Guillermo Montoya, Francisco J. Blanco and Agnès Gouble and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Sylvain Arnould

14 papers receiving 1.2k citations

Hit Papers

Multiplex Genome-Edited T-cell Manufacturing Platform for... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Arnould France 9 1.0k 452 417 149 134 15 1.3k
Agnès Gouble France 16 904 0.9× 635 1.4× 456 1.1× 175 1.2× 59 0.4× 37 1.3k
Jordan Jarjour United States 14 929 0.9× 240 0.5× 326 0.8× 62 0.4× 89 0.7× 21 1.1k
Anand Kornepati United States 15 1.2k 1.2× 341 0.8× 229 0.5× 51 0.3× 83 0.6× 22 1.7k
Shun‐Qing Liang United States 17 922 0.9× 200 0.4× 212 0.5× 38 0.3× 40 0.3× 32 1.2k
Michael T. Certo United States 9 684 0.7× 137 0.3× 200 0.5× 44 0.3× 86 0.6× 10 754
Shantanu Kumar United States 9 1.1k 1.1× 137 0.3× 381 0.9× 58 0.4× 66 0.5× 14 1.3k
Gwendolyn Binder-Scholl United States 7 1.1k 1.1× 761 1.7× 658 1.6× 174 1.2× 26 0.2× 11 1.7k
Joseph Hiatt United States 10 461 0.5× 145 0.3× 231 0.6× 56 0.4× 75 0.6× 11 770
Garrett R. Rettig United States 14 1.1k 1.1× 137 0.3× 331 0.8× 62 0.4× 75 0.6× 19 1.2k

Countries citing papers authored by Sylvain Arnould

Since Specialization
Citations

This map shows the geographic impact of Sylvain Arnould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Arnould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Arnould more than expected).

Fields of papers citing papers by Sylvain Arnould

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Arnould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Arnould. The network helps show where Sylvain Arnould may publish in the future.

Co-authorship network of co-authors of Sylvain Arnould

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Arnould. A scholar is included among the top collaborators of Sylvain Arnould based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Arnould. Sylvain Arnould is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Berger, Anne‐Emmanuelle, et al.. (2025). Monitoring of monoclonal antibody critical quality attributes and free amino acids in CHO bioprocesses using Raman spectroscopy and DUPLEX-based PLS modeling. Microchemical Journal. 218. 115583–115583. 1 indexed citations
2.
Boyer, John T., Anne‐Emmanuelle Berger, Martin Soucé, et al.. (2025). Monitoring of Nutrients, Metabolites, IgG Titer, and Cell Densities in 10 L Bioreactors Using Raman Spectroscopy and PLS Regression Models. Pharmaceutics. 17(4). 473–473. 2 indexed citations
3.
Poirot, Laurent, Brian Philip, Cécile Schiffer-Mannioui, et al.. (2015). Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies. Cancer Research. 75(18). 3853–3864. 468 indexed citations breakdown →
4.
Hermel, Jean‐Michel, Yannick Elipot, Sandrine Bretaud, et al.. (2015). A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish. PLoS ONE. 10(7). e0133986–e0133986. 19 indexed citations
5.
Smith, Julianne, Laurent Poirot, Brian Philip, et al.. (2015). UCART19, an allogeneic “off-the-shelf” adoptive T-cell immunotherapy against CD19+ B-cell leukemias.. Journal of Clinical Oncology. 33(15_suppl). 3069–3069. 1 indexed citations
6.
Derniame, Sophie, Hong Zhan, Laurent Poirot, et al.. (2014). Multiplex Genome Editing As a Platform for “Off-the-Shelf” Adoptive CAR T-Cell Immunotherapies. Blood. 124(21). 1111–1111. 4 indexed citations
7.
Gouble, Agnès, Brian Philip, Laurent Poirot, et al.. (2014). In Vivo Proof of Concept of Activity and Safety of UCART19, an Allogeneic “Off-the-Shelf” Adoptive T-Cell Immunotherapy Against CD19+ B-Cell Leukemias. Blood. 124(21). 4689–4689. 7 indexed citations
8.
Lemaire, Laëtitia, Laurent Poirot, Agnès Gouble, et al.. (2013). Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells. Journal for ImmunoTherapy of Cancer. 1(S1). 1 indexed citations
9.
Grosse, Stéphanie, Nicolas Huot, Sylvain Arnould, et al.. (2011). Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells. Molecular Therapy. 19(4). 694–702. 59 indexed citations
10.
Arnould, Sylvain, Christophe Delenda, Sylvestre Grizot, et al.. (2010). The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy. Protein Engineering Design and Selection. 24(1-2). 27–31. 72 indexed citations
11.
Redondo, Pilar Negrete, Jesús Prìeto, Inés G. Muñoz, et al.. (2008). Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature. 456(7218). 107–111. 129 indexed citations
12.
Prìeto, Jesús, Pilar Negrete Redondo, Daniel Padró, et al.. (2007). The C-terminal loop of the homing endonuclease I-CreI is essential for site recognition, DNA binding and cleavage. Nucleic Acids Research. 35(10). 3262–3271. 21 indexed citations
13.
Arnould, Sylvain, Christophe Perez, Jean‐Pierre Cabaniols, et al.. (2007). Engineered I-CreI Derivatives Cleaving Sequences from the Human XPC Gene can Induce Highly Efficient Gene Correction in Mammalian Cells. Journal of Molecular Biology. 371(1). 49–65. 107 indexed citations
14.
Smith, Julianne, Sylvestre Grizot, Sylvain Arnould, et al.. (2006). A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Research. 34(22). e149–e149. 231 indexed citations
15.
Arnould, Sylvain, Patrick Chames, Christophe Perez, et al.. (2005). Engineering of Large Numbers of Highly Specific Homing Endonucleases that Induce Recombination on Novel DNA Targets. Journal of Molecular Biology. 355(3). 443–458. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026